Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 2
  • 1
  • 24
  • 30
  • 13
  • 1
  • 29
  • 3
  • 27

Found 30 Stress trials

A listing of Stress medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
22 years - 65 years
All genders
The research study is being conducted to examine the effects of accelerated intermittent theta-burst stimulation (aiTBS), a form of transcranial magnetic stimulation, to the inferior parietal lobe (IPL) in a sample of BD patients who are currently depressed. This project will recruit patients aged 22-65 with symptoms of bipolar depression …
21 years - 75 years
All genders
To test if TMS to MRI-guided cortical targets can create neuronal activity changes in downstream regions of interest To determine if TMS-sEEG is a valid research approach to study circuit engagement and specific connections of deep brain nuclei in the human brain To investigate the effects of clinically relevant TMS …
99 years or below
All genders
Objectives 1) Evaluate the safety and feasibility of focused ultrasound to three brain targets Changes in VAS scores, Changes in pre- and post-study imaging, Changes in symptomatic checklist survey data Psychophysiology (heart rate, respiration, skin conductance), Y-BOCS score
99 years or below
All genders
This study will evaluate the efficacy and safety of brenipatide vs placebo as an add-on to stable standard of care (SoC) in adults with BD I/II in remission or near remission with residual symptoms. The primary measure is time to relapse. The study includes Screening (~4 weeks), Double-Blind Treatment (until …
99 years or below
All genders
The study evaluates the efficacy and safety of brenipatide vs. placebo as an add-on to ongoing MDD treatment. Eligible participants have MDD in remission or near remission with residual symptoms. They will complete a ~4-week Screening period before randomization, followed by a Double-Blind Adjunctive Treatment period until relapse, other discontinuation …
99 years or below
All genders
We are requesting a reliance agreement with Advarra for a randomized control trial using the ATTN201 device for the treatment of OCD. The ATTN201 device will provide low-intensity focused ultrasound to the subthalamic nucleus (STN). The device is a safe, easy-to-use, helmet-like device meant to be used in-clinic or at …
99 years or below
All genders
The dlPFC is increasingly being targeted with TMS to reduce anxiety expression; however, there is little mechanistic evidence supporting treatment. Thus, the objective of the current project is to develop an interleaved TMS/fMRI that can assess the effect of TMS protocols on neural and behavioral measures related to anxiety expression. …
99 years or below
All genders
Aim 1: Measure local shifts in cortical spectral dynamics following aiTBS. Aim 2: Measure network-specific shifts in task performance following aiTBS. Exploratory aim: Evaluate changes to resting state spectral dynamics in absence of stimulation after aiTBS
99 years or below
All genders
The study evaluates the efficacy and safety of Brenipatide vs. placebo as an add-on to ongoing MDD treatment. Eligible participants have MDD in remission or near remission with residual symptoms. They will complete a ~4-week Screening period before randomization, followed by a Double-Blind Adjunctive Treatment period until relapse, other discontinuation …
99 years or below
All genders
Obsessive-compulsive disorder (OCD) is a serious mental health condition that affects approximately 2.2 million adults in the United States. People with OCD experience unwanted, intrusive thoughts (obsessions) and feel compelled to perform repetitive behaviors (compulsions). This study is a randomized, sham-controlled trial evaluating the safety, tolerability, and target engagement of …
11 - 20 of 30